{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T20:12:50Z","timestamp":1783714370278,"version":"3.55.0"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,20]],"date-time":"2025-12-20T00:00:00Z","timestamp":1766188800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100006081","name":"Lounais-Suomen Sy\u00f6p\u00e4yhdistys","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006081","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinica Chimica Acta"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.cca.2025.120790","type":"journal-article","created":{"date-parts":[[2025,12,20]],"date-time":"2025-12-20T07:18:55Z","timestamp":1766215135000},"page":"120790","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Aberrantly glycosylated PSMA in urine as a potential marker for prostate cancer"],"prefix":"10.1016","volume":"582","author":[{"given":"Misba","family":"Khan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Md. Khirul","family":"Islam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pekka","family":"Taimen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter J.","family":"Bostr\u00f6m","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Urpo","family":"Lamminm\u00e4ki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janne","family":"Leivo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.cca.2025.120790_bb0005","doi-asserted-by":"crossref","DOI":"10.1002\/SMMD.20220020","article-title":"Nurturing the marriages of urinary liquid biopsies and nano-diagnostics for precision urinalysis of prostate cancer","volume":"2","author":"Liao","year":"2023","journal-title":"Smart Med."},{"issue":"1","key":"10.1016\/j.cca.2025.120790_bb0010","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1097\/JU.0000000000001691","article-title":"Specific detection of prostate cancer cells in urine by RNA in situ hybridization","volume":"206","author":"Eskra","year":"2021","journal-title":"J. Urol."},{"issue":"1","key":"10.1016\/j.cca.2025.120790_bb0015","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1186\/s12967-023-04424-9","article-title":"Prediction of clinically significant prostate cancer through urine metabolomic signatures: A large-scale validated study","volume":"21","author":"Huang","year":"2023","journal-title":"J. Transl. Med."},{"issue":"2","key":"10.1016\/j.cca.2025.120790_bb0020","first-page":"99","article-title":"Validation of a urine-based proteomics test to predict clinically significant prostate cancer: complementing mpMRI pathway","volume":"92","author":"Frantzi","year":"2025","journal-title":"Pathobiology"},{"issue":"1","key":"10.1016\/j.cca.2025.120790_bb0025","doi-asserted-by":"crossref","DOI":"10.1002\/rcm.8952","article-title":"Site- and structure-specific characterization of the human urinary N-glycoproteome with site-determining and structure-diagnostic product ions","volume":"35","author":"Shen","year":"2021","journal-title":"Rapid Commun. Mass Spectrom."},{"issue":"1","key":"10.1016\/j.cca.2025.120790_bb0030","doi-asserted-by":"crossref","DOI":"10.1080\/20013078.2020.1736935","article-title":"Unravelling the proteomic landscape of extracellular vesicles in prostate cancer by density-based fractionation of urine","volume":"9","author":"Dhondt","year":"2020","journal-title":"J. Extracell. Vesicles"},{"issue":"1","key":"10.1016\/j.cca.2025.120790_bb0035","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.juro.2013.02.018","article-title":"PCA3 molecular urine test as a predictor of repeat prostate biopsy outcome in men with previous negative biopsies: a prospective multicenter clinical study","volume":"190","author":"Gittelman","year":"2013","journal-title":"J. Urol."},{"issue":"5","key":"10.1016\/j.cca.2025.120790_bb0040","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/j.eururo.2016.04.012","article-title":"Detection of high-grade prostate cancer using a urinary molecular biomarker-based risk score","volume":"70","author":"Van Neste","year":"2016","journal-title":"Eur. Urol."},{"issue":"1","key":"10.1016\/j.cca.2025.120790_bb0045","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.eururo.2015.04.039","article-title":"Urine TMPRSS2: ERG plus PCA3 for individualized prostate cancer risk assessment","volume":"70","author":"Tomlins","year":"2016","journal-title":"Eur. Urol."},{"issue":"4","key":"10.1016\/j.cca.2025.120790_bb0050","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1038\/s41391-020-0237-z","article-title":"Clinical utility of the exosome based ExoDx prostate (IntelliScore) EPI test in men presenting for initial biopsy with a PSA 2\u201310ng\/mL","volume":"23","author":"Tutrone","year":"2020","journal-title":"Prostate Cancer Prostatic Dis."},{"issue":"2","key":"10.1016\/j.cca.2025.120790_bb0055","doi-asserted-by":"crossref","first-page":"513","DOI":"10.3390\/cancers12020513","article-title":"The urinary transcriptome as a source of biomarkers for prostate cancer","volume":"12","author":"Sol\u00e9","year":"2020","journal-title":"Cancers (Basel)"},{"issue":"3","key":"10.1016\/j.cca.2025.120790_bb0060","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.cpet.2024.03.001","article-title":"Prostate-specific membrane antigen: diagnostics","volume":"19","author":"Alberts","year":"2024","journal-title":"PET Clin."},{"issue":"5","key":"10.1016\/j.cca.2025.120790_bb0065","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1002\/pros.24666","article-title":"Prostate-specific membrane antigen (PSMA) glycoforms in prostate cancer patients seminal plasma","volume":"84","author":"Mackay","year":"2024","journal-title":"Prostate"},{"issue":"1","key":"10.1016\/j.cca.2025.120790_bb0070","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1186\/s40001-023-01590-w","article-title":"Hotspots and frontiers in PSMA research for prostate cancer: a bibliometric and visualization analysis over the past 20 years","volume":"28","author":"Zhang","year":"2023","journal-title":"Eur. J. Med. Res."},{"key":"10.1016\/j.cca.2025.120790_bb0075","doi-asserted-by":"crossref","DOI":"10.3390\/cancers16244263","article-title":"Current clinical applications of PSMA-PET for prostate cancer diagnosis, staging, and treatment","author":"von Stauffenberg","year":"2024","journal-title":"Cancers"},{"issue":"3","key":"10.1016\/j.cca.2025.120790_bb0080","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1007\/s12094-022-02983-9","article-title":"Urine-derived exosomal PSMA is a promising diagnostic biomarker for the detection of prostate cancer on initial biopsy","volume":"25","author":"Wang","year":"2023","journal-title":"Clin. Transl. Oncol."},{"key":"10.1016\/j.cca.2025.120790_bb0085","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14122987","article-title":"Prostate-specific membrane antigen (PSMA)-positive extracellular vesicles in urine\u2014a potential liquid biopsy strategy for prostate cancer diagnosis?","author":"Allelein","year":"2022","journal-title":"Cancers"},{"issue":"1","key":"10.1016\/j.cca.2025.120790_bb0090","article-title":"A comprehensive view of N-glycosylation as clinical biomarker in prostate cancer. BBA- reviews on","volume":"1880","author":"Eggermont","year":"2025","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.cca.2025.120790_bb0095","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-95417-5","article-title":"Alterations in protein expression and site-specific N-glycosylation of prostate cancer tissues","volume":"11","author":"Sug\u00e1r","year":"2021","journal-title":"Sci. Rep."},{"issue":"4","key":"10.1016\/j.cca.2025.120790_bb0100","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.21037\/tau-20-964","article-title":"Narrative review of urinary glycan biomarkers in prostate cancer","volume":"10","author":"Hatakeyama","year":"2021","journal-title":"Transl. Androl. Urol."},{"issue":"1","key":"10.1016\/j.cca.2025.120790_bb0105","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1186\/s40364-023-00520-6","article-title":"Lectins as potential tools for cancer biomarker discovery from extracellular vesicles","volume":"11","author":"Islam","year":"2023","journal-title":"Biomark. Res."},{"issue":"17","key":"10.1016\/j.cca.2025.120790_bb0110","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1021\/acs.biochem.1c00009","article-title":"Crystal structure of the carbohydrate recognition domain of the human macrophage galactose C-type lectin Bound to GalNAc and the tumor-associated Tn antigen","volume":"60","author":"Abba","year":"2021","journal-title":"Biochemistry"},{"issue":"559","key":"10.1016\/j.cca.2025.120790_bb0115","article-title":"Lectin-nanoparticle concept for free PSA glycovariant providing superior cancer specificity","volume":"1","author":"Kekki","year":"2024","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.cca.2025.120790_bb0120","doi-asserted-by":"crossref","DOI":"10.1002\/nano.202400018","article-title":"Tetraspanin immunoassay for the detection of extracellular vesicles and renal cell carcinoma","volume":"5","author":"Khan","year":"2024","journal-title":"Nano Select"},{"issue":"10","key":"10.1016\/j.cca.2025.120790_bb0125","doi-asserted-by":"crossref","first-page":"e64","DOI":"10.1002\/jex2.64","article-title":"Integrins are enriched on aberrantly fucosylated tumour-derived urinary extracellular vesicles","volume":"1","author":"Islam","year":"2022","journal-title":"J. Extracell. Biol."},{"issue":"8","key":"10.1016\/j.cca.2025.120790_bb0130","first-page":"e1540","article-title":"Primary breast cancer biomarkers based on glycosylation and extracellular vesicles detected from human serum","volume":"5","author":"Ter\u00e4v\u00e4","year":"2022","journal-title":"Cancer Rep (Hoboken)"},{"issue":"3","key":"10.1016\/j.cca.2025.120790_bb0135","doi-asserted-by":"crossref","first-page":"2247","DOI":"10.1021\/acs.analchem.8b04829","article-title":"Identification of multisialylated LacdiNAc structures as highly prostate cancer specific glycan signatures on PSA","volume":"91","author":"Haga","year":"2019","journal-title":"Anal. Chem."},{"issue":"14","key":"10.1016\/j.cca.2025.120790_bb0140","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1002\/pros.70014","article-title":"Altered Glycosylation of PSA in Prostate Cancer Tissue","volume":"85","author":"Koistinen","year":"2025","journal-title":"Prostate"},{"issue":"2","key":"10.1016\/j.cca.2025.120790_bb0145","doi-asserted-by":"crossref","DOI":"10.1098\/rsfs.2018.0077","article-title":"Prostate-specific antigen glycoprofiling as diagnostic and prognostic biomarker of prostate cancer","volume":"9","author":"Tkac","year":"2019","journal-title":"Interface Focus"},{"issue":"1","key":"10.1016\/j.cca.2025.120790_bb0150","doi-asserted-by":"crossref","first-page":"18974","DOI":"10.1038\/s41598-020-75526-3","article-title":"Characterisation of the main PSA glycoforms in aggressive prostate cancer","volume":"10","author":"Gratac\u00f3s-Mulleras","year":"2020","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.cca.2025.120790_bb0155","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1002\/pros.24254","article-title":"Glycoforms of human prostate-specific membrane antigen (PSMA) in human cells and prostate tissue","volume":"82","author":"Yuan","year":"2022","journal-title":"Prostate"},{"issue":"8","key":"10.1016\/j.cca.2025.120790_bb0160","doi-asserted-by":"crossref","first-page":"3043","DOI":"10.7150\/thno.92612","article-title":"PSMA-targeted radiotheranostics in modern nuclear medicine: then, now, and what of the future?","volume":"14","author":"Sallam","year":"2024","journal-title":"Theranostics"},{"issue":"1","key":"10.1016\/j.cca.2025.120790_bb0165","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2024.52971","article-title":"PSMA-PET\/CT findings in patients with high-risk biochemically recurrent prostate cancer with no metastatic disease by conventional imaging","volume":"8","author":"Holzgreve","year":"2025","journal-title":"JAMA Netw. Open"},{"issue":"11","key":"10.1016\/j.cca.2025.120790_bb0170","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1002\/pros.24724","article-title":"Increased \u03b12,3-sialyl N-glycosylated prostate-specific membrane antigen (PSMA) in post-DRE urine is associated with high grade group prostate cancer","volume":"84","author":"Mackay","year":"2024","journal-title":"Prostate"},{"issue":"3","key":"10.1016\/j.cca.2025.120790_bb0175","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1002\/pros.22918","article-title":"Urinary prostate protein glycosylation profiling as a diagnostic biomarker for prostate cancer","volume":"75","author":"Vermassen","year":"2015","journal-title":"Prostate"},{"issue":"Pt 4","key":"10.1016\/j.cca.2025.120790_bb0180","article-title":"Increased N-glycosylation of PSMA by GnT-V enhances tumor malignancy through interacting with JAK2 and the subsequent STAT3-mediated transcriptional activation in prostate cancer","volume":"307","author":"Shi","year":"2025","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.cca.2025.120790_bb0185","article-title":"CA-125 glycovariant assays enhance diagnostic sensitivity in the detection of epithelial ovarian cancer","author":"Moukas","year":"2025","journal-title":"Clin. Chem. Lab. Med."},{"issue":"23","key":"10.1016\/j.cca.2025.120790_bb0190","doi-asserted-by":"crossref","first-page":"17078","DOI":"10.3390\/ijms242317078","article-title":"Ligand recognition by the macrophage galactose-type C-type lectin: self or non-self? -A way to trick the host's immune system","volume":"24","author":"Szczykutowicz","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"5","key":"10.1016\/j.cca.2025.120790_bb0195","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1111\/imcb.70011","article-title":"The macrophage galactose-type C-type lectin 1 receptor plays a major role in mediating colitis-associated colorectal cancer malignancy","volume":"103","author":"Nieto-Ya\u00f1ez","year":"2025","journal-title":"Immunol. Cell Biol."},{"issue":"11","key":"10.1016\/j.cca.2025.120790_bb0200","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1093\/glycob\/cwad083","article-title":"Tn antigen interactions of macrophage galactose-type lectin (MGL) in immune function and disease","volume":"33","author":"Tumoglu","year":"2023","journal-title":"Glycobiology"},{"issue":"10","key":"10.1016\/j.cca.2025.120790_bb0205","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1373\/clinchem.2016.257691","article-title":"A nanoparticle-lectin immunoassay improves discrimination of serum CA125 from malignant and benign sources","volume":"62","author":"Gidwani","year":"2016","journal-title":"Clin. Chem."},{"issue":"4","key":"10.1016\/j.cca.2025.120790_bb0210","doi-asserted-by":"crossref","first-page":"129513","DOI":"10.1016\/j.bbagen.2020.129513","article-title":"Characterization of Macrophage Galactose-type Lectin (MGL) ligands in colorectal cancer cell lines","volume":"2020","author":"Pirro","year":"1864","journal-title":"Biochim. Biophys. Acta Gen. Subj."},{"issue":"12","key":"10.1016\/j.cca.2025.120790_bb0215","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.3390\/healthcare13121381","article-title":"The effectiveness and harms of PSA-based prostate cancer screening: a systematic review","volume":"13","author":"Oh","year":"2025","journal-title":"Healthcare (Basel)"}],"updated-by":[{"DOI":"10.1016\/j.cca.2025.120818","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2026,1,3]],"date-time":"2026-01-03T00:00:00Z","timestamp":1767398400000}},{"DOI":"10.1016\/j.cca.2025.120818","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000}}],"container-title":["Clinica Chimica Acta"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898125006692?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898125006692?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T19:21:30Z","timestamp":1783711290000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009898125006692"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":43,"alternative-id":["S0009898125006692"],"URL":"https:\/\/doi.org\/10.1016\/j.cca.2025.120790","relation":{},"ISSN":["0009-8981"],"issn-type":[{"value":"0009-8981","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Aberrantly glycosylated PSMA in urine as a potential marker for prostate cancer","name":"articletitle","label":"Article Title"},{"value":"Clinica Chimica Acta","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cca.2025.120790","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"120790"}}